- Home
- CSTL vs MUJ Comparison
CSTL vs MUJ Comparison
Compare CSTL & MUJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- MUJ
- Stock Information
- Founded
- CSTL 2007
- MUJ 1998
- Country
- CSTL United States
- MUJ United States
- Employees
- CSTL N/A
- MUJ N/A
- Industry
- CSTL Medical Specialities
- MUJ Investment Bankers/Brokers/Service
- Sector
- CSTL Health Care
- MUJ Finance
- Exchange
- CSTL Nasdaq
- MUJ Nasdaq
- Market Cap
- CSTL 697.9M
- MUJ 606.3M
- IPO Year
- CSTL 2019
- MUJ N/A
- Fundamental
- Price
- CSTL $21.62
- MUJ $11.42
- Analyst Decision
- CSTL Strong Buy
- MUJ
- Analyst Count
- CSTL 6
- MUJ 0
- Target Price
- CSTL $37.67
- MUJ N/A
- AVG Volume (30 Days)
- CSTL 423.4K
- MUJ 108.0K
- Earning Date
- CSTL 11-03-2025
- MUJ 01-01-0001
- Dividend Yield
- CSTL N/A
- MUJ 4.36%
- EPS Growth
- CSTL N/A
- MUJ N/A
- EPS
- CSTL N/A
- MUJ N/A
- Revenue
- CSTL $346,269,000.00
- MUJ N/A
- Revenue This Year
- CSTL N/A
- MUJ N/A
- Revenue Next Year
- CSTL N/A
- MUJ N/A
- P/E Ratio
- CSTL N/A
- MUJ N/A
- Revenue Growth
- CSTL 20.40
- MUJ N/A
- 52 Week Low
- CSTL $14.59
- MUJ $9.74
- 52 Week High
- CSTL $35.84
- MUJ $11.70
- Technical
- Relative Strength Index (RSI)
- CSTL 50.19
- MUJ 70.87
- Support Level
- CSTL $22.54
- MUJ $10.88
- Resistance Level
- CSTL $24.74
- MUJ $11.49
- Average True Range (ATR)
- CSTL 1.14
- MUJ 0.09
- MACD
- CSTL -0.28
- MUJ 0.04
- Stochastic Oscillator
- CSTL 28.93
- MUJ 88.52
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.
BlackRock MuniHoldings New Jersey Quality Fund Inc is a closed-end management investment company. The investment objective of the company is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund invests in a portfolio of long-term, investment-grade New Jersey municipal obligations.